Associated Papers
Mechanism of action of non-camptothecin inhibitor Genz-644282 in topoisomerase I inhibition.
Nishida M et al.
Communications Biology, 2022
New Topoisomerase I mutations are associated with resistance to camptothecin.
Gongora C et al.
Molecular Cancer, 2011
Topoisomerase I gene mutations at F270 in the large subunit and N184 in the small subunit contribute to the resistance mechanism of the unicellular parasite Leishmania donovani towards 3,3'-diindolylmethane.
Roy A et al.
Antimicrobial Agents and Chemotherapy, 2009
Effects of drug efflux proteins and topoisomerase I mutations on the camptothecin analogue gimatecan.
Gounder MK et al.
Investigational New Drugs, 2008
Retroviral expression of a mutant (Gly-533) human DNA topoisomerase I cDNA confers a dominant form of camptothecin resistance.
Yanase K et al.
International Journal of Cancer, 1999
Characterization of Camptothecin-induced Genomic Changes in the Camptothecin-resistant T-ALL-derived Cell Line CPT-K5.
Kjeldsen E et al.
Cancer Genomics & Proteomics, 0
Select a paper to view details